FDA review Tamiflu's effects 1,800 children brains Rumsfeld's has $5 -$25 Million Stock
-
-
-
-
- CarolynGillis
- added this
-
more from Tech:
http://current.com/items/87894921_fda_review_tamiflu_s_brain_effects_...
A Food and Drug Administration panel on Tuesday will review reports of abnormal behavior and other brain effects in more than 1,800 children who had taken the flu medicine Tamiflu since its approval in 1999, including 55 in the USA.Twenty-two of the U.S. reports were considered "serious," with symptoms such as convulsions, delirium or delusions, says Terry Hurley, spokesman for drugmaker Roche Laboratories.
None of the U.S. cases resulted in death. But in Japan, Hurley says, five deaths have been reported in children under 16 as a result of neurological or psychiatric problems. "Four were fatal falls, and one was encephalitis in a patient with leukemia," he says.
In addition, in people ages 17 to 21, there were two deaths in Japan, one a "fatal accident with abnormal behavior," Hurley says, and the second as a result of encephalopathy, a brain infection. Seven adult deaths attributed to neuropsychiatric problems also have been reported in Japan.
http://www.snopes.com/politics/medical/tamiflu.asp
Here is what Snopes has to say about this
-
- groups:
- Tech, News, Green, News and Politics, 5 more
-
- tags:
- News, News and Politics, Politics, Green, 10 more
-
-
queenofit
-
Why can't the government endorse products that aren't harmful and boost our immune systems? (rhetorical)
I worked in a Drug Rehab a few years ago, and there was an awful virus going around. It was a 24hr/7day a week facility, with lots of young people checking in, and checking out. They passed their germs around the place pretty good, and the staff was no better. All in all, this virus just kept hanging on; some had to got get antibiotics up to 2 and 3 times.
I finally got it, and had to go get some myself, first time to get a dose of antibiotics in years.
ONE GUY; (the director) never got sick, and he was in the middle of all those kids and staff, worked long hard hours, certainly stressed out (given), and I asked him "what are you doing?' what he told me, vit c, Echinacea and no dairy.
Since that time, when the "season" hits, I really make an EXTRA effort to boost my immune system, and I have found what works best for me. If I die tomorrow, it won't be from that nasty so called flu vaccine, thank you very much!
- 10 months ago
-
queenofit
-
-
carmalite
-
Will there never be an end to what this cabal has done in 8 years? How rich did Cheney, Rummy, and Condi get from the war, oil subsidies, and on and on?
- 10 months ago
-
carmalite
-
-
ras_menelik
-
-
April 27 (Bloomberg) -- GlaxoSmithKline Plc’s flu drug Relenza beat Roche Holding AG’s Tamiflu in sales to governments for the first time last quarter, a sign authorities are seeking a broader range of medicines to protect against a pandemic.
Government orders of Relenza were 20 percent higher than those for Tamiflu in the first quarter, according to data from both companies released before the current swine flu outbreak. Biota Holdings Ltd., which earns royalties on Relenza sales, jumped 82 percent today on speculation sales will gain as concerns mount that the flu may spread.
Demand for Relenza was stoked by reports of widespread resistance of H1N1, a common seasonal flu virus, to Tamiflu. The U.K. and Japan increased orders for the drug to prepare for a possible influenza pandemic on concern Tamiflu-evading seasonal flu could exchange genes with a pandemic strain, making that pill a weaker weapon against a global contagion. Almost all H1N1 samples tested last winter were resistant to Tamiflu, the World Health Organization said.
“Governments are balancing their stockpiles” by including more Relenza, said Stephen Rea, a spokesman for London-based Glaxo, in an April 24 phone interview. “Our expectation would be that other governments would follow suit. Our view would be the U.S. government would also be persuaded.”
Shares Gain
Glaxo shares gained 58 pence, or 5.8 percent, to 1,064 pence as of 3:29 p.m. in London. Roche climbed as much as 5.5 percent, its biggest gain since March 10, and traded up 3.5 percent at 144.5 Swiss francs at 4:30 p.m. in Swiss trading.
Biota, based in Melbourne, had its biggest gain since October 1987 and closed at A$1.58 in Sydney trading, valuing the company at A$276 million ($197 million). The shares closed at their highest price in 2 1/2 years after the WHO called swine flu a “public health emergency of international concern.”
Governments ordered about 220 million pounds ($322 million) of Relenza in the three months ending in March, Rea said. That compares with orders for Tamiflu of 304 million francs ($266 million), Basel, Switzerland-based Roche said April 17.
Total sales of Tamiflu in the first quarter, including revenue from doctors’ prescriptions of the drug for seasonal flu, were 401 million Swiss francs, compared with 222 million pounds for Relenza. Seasonal sales of Relenza were “a couple of million” pounds in the quarter and sales for stockpiles were the “vast majority” of the total, Rea said.
- 10 months ago
-
ras_menelik
